Chronic Total Occlusions (CTO): 60 Second Insights
Published: 08 March 2018
-
Views:
2186
-
Likes:
7
-
Views:
2186
-
Likes:
7
-
Up Next -
1m 7sPart 9 | Session 5 Patrick Serruys
-
1m 18sPart 9 | Session 6 Carlos Di Mario
-
1m 7sPart 9 | Session 7 Gerald Werner
-
37sPart 1 Ajay Kirtane Ajay J Kirtane
-
52sPart 2 | Session 1 Ajay Kirtane Ajay J Kirtane
-
1mPart 2 | Session 2 Simon Walsh Simon J Walsh
-
49sPart 2 | Session 3 Paul Knaapen Paul Knaapen
-
27sPart 2 | Session 4 Emmanouil Brilakis Emmanouil S Brilakis
-
1m 36sPart 2 | Session 5 Carlos Di Mario Carlo Di Mario
-
55sPart 2 | Session 6 Patrick Serruys Patrick W Serruys
-
55sPart 2 | Session 7 Gerald Werner Gerald S Werner
-
25sPart 3 | Session 1 Ajay Kirtane Ajay J Kirtane
-
46sPart 3 | Session 2 Simon Walsh Simon J Walsh
-
1mPart 3 | Session 3 Paul Knaapen Paul Knaapen
-
35sPart 3 | Session 4 Emmanouil Brilakis Emmanouil S Brilakis
-
1m 9sPart 3 | Session 5 Carlos Di Mario Carlo Di Mario
-
57sPart 3 | Session 6 Patrick Serruys Patrick W Serruys
-
1m 12sPart 3 | Session 7 Gerald Werner Gerald S Werner
-
46sPart 4 | Session 1 Ajay Kirtane
-
1m 6sPart 4 | Session 2 Simon Walsh Simon J Walsh
-
1m 7sPart 4 | Session 3 Paul Knaapen Paul Knaapen
-
46sPart 4 | Session 4 Emmanouil Brilakis Emmanouil S Brilakis
-
1m 11sPart 4 | Session 5 Patrick Serruys Patrick W Serruys
-
1m 24sPart 4 | Session 6 Gerald Werner Gerald S Werner
-
38sPart 5 | Session 1 Ajay Kirtane Ajay J Kirtane
-
46sPart 5 | Session 2 Simon Walsh Simon J Walsh
-
55sPart 5 | Session 3 Paul Knaapen Paul Knaapen
-
41sPart 5 | Session 4 Emmanouil Birlakis Emmanouil S Brilakis
-
56sPart 5 | Session 5 Carlos Di Mario Carlo Di Mario
-
50sPart 5 | Session 6 Patrick Serruys Patrick W Serruys
-
47sPart 5 | Session 7 Gerald Werner Gerald S Werner
-
42sPart 6 | Session 1 Ajay Kirtane Ajay J Kirtane
-
1m 1sPart 6 | Session 2 Simon Walsh Simon J Walsh
-
1m 2sPart 6 | Session 3 Paul Knaapen Paul Knaapen
-
35sPart 6 | Session 4 Emmanouil Birkalis Emmanouil S Brilakis
-
40sPart 6 | Session 5 Carlos Di Mario Carlo Di Mario
-
1m 18sPart 6 | Session 6 Patrick Serruys Patrick W Serruys
-
1m 7sPart 6 | Session 7 Gerald Werner Gerald S Werner
-
57sPart 7 | Session 1 Ajay Kirtane Ajay J Kirtane
-
1m 15sPart 7 | Session 2 Simon Walsh Simon J Walsh
-
1m 5sPart 7 | Session 3 Paul Knaapen Paul Knaapen
-
49sPart 7 | Session 4 Emmanouil Birkalis Emmanouil S Brilakis
-
1m 25sPart 7 | Session 5 Carlos Di Mario Carlo Di Mario
-
1m 36sPart 7 | Session 6 Patrick Serruys Patrick W Serruys
-
1m 24sPart 7 | Session 7 Gerald Werner Gerald S Werner
-
45sPart 8 | Session 1 Ajay Kirtane Ajay J Kirtane
-
37sPart 8 | Session 2 Simon Walsh Simon J Walsh
-
1mPart 8 | Session 3 Paul Knaapen Paul Knaapen
-
37sPart 8 | Session 4 Emmanouil Birlakis Emmanouil S Brilakis
-
1m 4sPart 8 | Session 5 Carlos Di Mario Carlo Di Mario
-
1m 5sPart 8 | Session 6 Patrick Serruys Patrick W Serruys
-
1m 7sPart 8 | Session 7 Gerald Werner Gerald S Werner
-
48sPart 9 | Session 1 Ajay Kirtane Ajay J Kirtane
-
52sPart 9 | Session 2 Simon Walsh Simon J Walsh
-
1m 4sPart 9 | Session 3 Paul Knaappen Paul Knaapen
Overview
A series of 60-second interviews where Ajay Kirtane, Simon Walsh, Paul Knappen, Emmanouil Brilakis, Carlos Di Mario, Partick Serruys and Gerald Werner provide their thoughts on CTOs.
More from this programme
Part 1
Are CTOs important to the management of angina in your patients?
| 1 session | |
| Ajay Kirtane | Watch now |
Part 2
What trials are needed to advance the CTO field?
Part 3
What is your preferred imaging modality for CTOs?
Part 4
What is your preferred CTO wire strategy, and why?
Part 5
What is the biggest advance in CTO treatment in the past 5 years?
Part 6
What devices should be developed to further advance CTO management?
Part 7
The data for CTO is mixed, with clinical trials showing no clear benefit, should we keep on doing CTO's?
Part 8
Retrograde or anterograde? What is your preferred strategy?
Part 9
How would you recommend someone starts a CTO program?
Faculty Biographies
Emmanouil S Brilakis
Director of the Center for Complex Coronary Interventions
Dr Emmanouil Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI is Director of the Center for Complex Coronary Interventions at the Minneapolis Heart Institute.
Dr Brilakis graduated from Lycee Leonin de Patissia and received his medical degree from the National Kapodistrian University of Athens, Greece. He trained in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology at the Mayo Clinic. He also completed a Masters in Clinical Research at the Mayo Clinic and a PhD in Clinical Research at the National Kapodistrian University of Athens, Greece. He served as director of the cardiac catheterization laboratories at VA North Texas Health Care System from 2004-2016.